IBD has been previously associated with increased levels of TNFα (67) with upregulation of TNFα mRNA in colonic tissue in patients with Crohn's Disease (68) and Ulcerative Colitis (69) and many current therapeutic regimens involve a focus on blocking signaling through this molecule. The gene discussed is TNF; the disease is ulcerative colitis.